Holen Sie sich die Stockscreener-App
2.31
2.67%
0.06
Handel nachbörslich:
2.48
0.17
+7.36%
Schlusskurs vom Vortag:
$2.25
Offen:
$2.24
24-Stunden-Volumen:
6.28M
Relative Volume:
1.98
Marktkapitalisierung:
$257.88M
Einnahmen:
$1.88B
Nettoeinkommen (Verlust:
$-534.51M
KGV:
-0.4487
EPS:
-5.1483
Netto-Cashflow:
$4.76M
1W Leistung:
+6.45%
1M Leistung:
-27.13%
6M Leistung:
-72.00%
1J Leistung:
-76.88%
1-Tages-Spanne:
$2.215
$2.355
1-Wochen-Bereich:
$2.095
$2.355
52-Wochen-Spanne:
$2.095
$12.06
Evolent Health Inc Stock (EVH) Company Profile
Firmenname
Evolent Health Inc
Sektor
Branche
Telefon
571-389-6000
Adresse
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
2.31 | 251.19M | 1.88B | -534.51M | 4.76M | -5.1483 |
VEEV
Veeva Systems Inc
|
174.64 | 28.42B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
47.30 | 8.47B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
43.51 | 8.28B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
83.44 | 7.15B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
23.63 | 4.55B | 1.10B | 112.09M | 283.19M | 0.6096 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-11-13 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-03 | Bestätigt | BTIG Research | Buy |
| 2024-11-08 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | Hochstufung | Truist | Hold → Buy |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-01 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-10-16 | Eingeleitet | UBS | Buy |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2022-11-01 | Eingeleitet | Truist | Hold |
| 2022-07-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-11-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Neutral |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-07-06 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | Herabstufung | Goldman | Buy → Neutral |
| 2020-06-02 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-06-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-04-24 | Fortgesetzt | JP Morgan | Neutral |
| 2017-09-20 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2017-01-13 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | Fortgesetzt | JP Morgan | Overweight |
| 2016-08-05 | Bestätigt | FBR Capital | Outperform |
| 2016-07-26 | Eingeleitet | Jefferies | Buy |
| 2016-07-13 | Bestätigt | FBR Capital | Outperform |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
| 2016-01-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-06-30 | Eingeleitet | Goldman | Buy |
| 2015-06-30 | Eingeleitet | JP Morgan | Overweight |
| 2015-06-30 | Eingeleitet | Leerink Partners | Outperform |
| 2015-06-30 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Evolent Health Inc Aktie (EVH) Neueste Nachrichten
Evolent Health (EVH) price target decreased by 32.38% to 6.01 - MSN
Context Capital Management, LLC's Evolent Health Inc(EVH) Holding History - GuruFocus
Evolent Health, Inc. (9EH.F) stock price, news, quote and history - sg.finance.yahoo.com
EVH Stock Price, Quote & Chart | EVOLENT HEALTH INCA (NYSE:EVH) - ChartMill
Chart Watch: Is Evolent Health Inc stock a top performer YTD2026 Big Picture & Safe Capital Allocation Plans - baoquankhu1.vn
What is Evolent Health Incs 5 year growth outlookMarket Weekly Review & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Can Evolent Health Inc continue delivering strong returns2026 Trends & Community Trade Idea Sharing - baoquankhu1.vn
Smart Money: Can Evolent Health Inc continue delivering strong returnsWeekly Investment Report & Verified Momentum Stock Alerts - baoquankhu1.vn
Market Sell-Off: Stocks Drop on Geopolitical Uncertainty and Oil Price FearsNews and Statistics - IndexBox
Evolent Health Receives $6.04 Average Price Target from Analysts - National Today
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know - Yahoo Finance
[SCHEDULE 13G/A] Evolent Health, Inc. Amended Passive Investment Disclosure - stocktitan.net
Aug Selloffs: Is Evolent Health Inc stock forming a cup and handle2026 Breakouts & Accurate Buy Signal Alerts - baoquankhu1.vn
Aug Setups: How sensitive is Evolent Health Inc to inflation2026 EndofMonth & Growth Focused Entry Point Reports - baoquankhu1.vn
Will Evolent Health Inc benefit from geopolitical trendsEarnings Risk Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Aug Macro: How does Evolent Health Inc score in quality rankings2026 Decliners & Expert Verified Movement Alerts - baoquankhu1.vn
Evolent Health, Inc (NYSE:EVH) Given Consensus Recommendation of "Moderate Buy" by Brokerages - marketbeat.com
Small-Cap Stock Risks: Declining Demand at Luxfer & Financial Strain at Evolent HealthNews and Statistics - IndexBox
Evolent announces appointment of Archie Mayani as chief product officer - The AI Journal
Evolent Appoints Archie Mayani as Chief Product Officer - citybiz
Evolent Health Appoints New Chief Product Officer - Intellectia AI
Amazon and UnitedHealth veteran takes top product role at Evolent - stocktitan.net
Doctor behind Cityblock joins Foodsmart to expand food as medicine for Medicaid - Stock Titan
Evolent Health at Oppenheimer Conference: Strategic Growth and Financial Focus - ca.investing.com
EVH: Strong pipeline, conservative guidance, and focus on profitability drive growth outlook - TradingView
Fund Flows: What is the next catalyst for Evolent Health Inc2026 Review & Pattern Based Trade Signal System - baoquankhu1.vn
Forecast Cut: Is Evolent Health Inc currently under institutional pressure2026 Technicals & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Eventide Asset Management LLC Purchases 2,205,659 Shares of Evolent Health, Inc $EVH - MarketBeat
8 Knots Management LLC Lowers Position in Evolent Health, Inc $EVH - MarketBeat
Investor Alert: Unprofitable Companies with High Financial Risk in 2026News and Statistics - IndexBox
Evolent Health downgraded at KeyBanc on EBITDA recovery concerns - MSN
Evolent Health (NYSE:EVH) Shares Cross Below 50-Day Moving AverageHere's What Happened - MarketBeat
Aug Analyst Calls: What is Evolent Health Incs 5 year growth outlookQuarterly Portfolio Review & Weekly Watchlist of Top Performers - baoquankhu1.vn
Evolent Health, American Oncology Network Partner to Streamline Cancer Care - MSN
Gainers Report: How sensitive is Evolent Health Inc to inflationMarket Activity Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn
How Evolent Health Inc Class stock expands through international markets2026 Macro Impact & Verified Trade Idea Suggestions - Naître et grandir
Precision Trading with Evolent Health Inc Class A (EVH) Risk Zones - Stock Traders Daily
How The Evolent Health (EVH) Investment Story Is Shifting After Reserves Reset And Higher Leverage - Yahoo Finance
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance
Profit Recap: Is Madison Square Garden Entertainment Corp stock influenced by commodity pricesWeekly Trend Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Evolent Health (NYSE: EVH) CEO reports PSU grant and tax-withheld share dispositions - Stock Titan
Evolent Health (EVH) president awarded PSUs and withholds shares for taxes - Stock Titan
Evolent Health (EVH) CAO awarded PSUs while shares withheld for taxes - Stock Titan
Evolent Health (EVH) CFO awarded 429,041 performance share units tied to 2027–2029 stock goals - Stock Titan
EVH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
William Blair Maintains Evolent Health(EVH.US) With Buy Rating - Moomoo
Cowen Maintains Buy on Evolent Health (EVH) March 2026, PT Cut to $7 - Meyka
TD Cowen cuts Evolent Health stock price target to $7 on 2026 outlook - Investing.com Canada
Oppenheimer Cuts Evolent Health (NYSE:EVH) Price Target to $6.00 - MarketBeat
Evolent Health (EVH) Receives Updated Analyst Rating from Oppenh - GuruFocus
Oppenheimer Adjusts Evolent Health Price Target to $6 From $12, Maintains Outperform Rating - marketscreener.com
Finanzdaten der Evolent Health Inc-Aktie (EVH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.79%
1.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):